These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7333861)

  • 21. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orally administered clonidine as a secretagogue of growth hormone and as a thymotrophic agent in dogs of various ages.
    Morrison WB; Goff BL; Stewart-Brown B; Incefy GS; Arp LH; Roth JA
    Am J Vet Res; 1990 Jan; 51(1):65-70. PubMed ID: 2301821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonidine (Haemiton) as a reliable stimulus of growth hormone secretion in patients with short stature.
    Keller E; Sorger D; Willgerodt H
    Exp Clin Endocrinol; 1983 May; 81(3):315-20. PubMed ID: 6684063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral clonidine advances spermatogenesis in oligozoospermic patients with spermatogenetic maturation arrest.
    Terada H; Fujita K; Otsuka A; Shinbo H; Mugiya S; Ozono S
    Int J Urol; 2005 Sep; 12(9):815-20. PubMed ID: 16201978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral clonidine test for growth hormone release (author's transl)].
    Moreno Romero F; Aparicio Palomino A; Espinosa Ruiz-Cabal J; Cruz Ortega J; Requena Guerrero F; Cardesa García JJ
    An Esp Pediatr; 1981 Apr; 14(4):254-8. PubMed ID: 7283286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone response to growth hormone-releasing hormone and clonidine in depression.
    Gann H; Riemann D; Stoll S; Berger M; Müller WE
    Biol Psychiatry; 1995 Sep; 38(5):325-9. PubMed ID: 7495927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration.
    Strijks E; van't Hof M; Sweep F; Lenders JW; Oyen WJ; Horstink MW
    J Neurol; 2002 Sep; 249(9):1206-10. PubMed ID: 12242540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional aspects of genetic variability in the GH genomic region.
    Gloria-Bottini F; Amante A; Lucarelli P; Saccucci P; Martinoli R; Bottini E
    J Endocrinol; 2007 Apr; 193(1):85-92. PubMed ID: 17400806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor-I (IGF-I) screening for the diagnosis of growth hormone (GH) deficiency.
    Sriphrapradang A; Mahachoklertwattana P; Choubtum L; Preeyasombat C
    J Med Assoc Thai; 1997 Jan; 80(1):51-5. PubMed ID: 9078817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined alpha-adrenergic stimulation results in biphasic response of growth hormone release in man.
    Iovino M; Monteleone P; Steardo L
    J Clin Endocrinol Metab; 1988 Jan; 66(1):217-20. PubMed ID: 2826526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonidine is a better test for growth hormone deficiency than insulin hypoglycaemia.
    Fraser NC; Seth J; Brown NS
    Arch Dis Child; 1983 May; 58(5):355-8. PubMed ID: 6344804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of estrogen on growth hormone following clonidine stimulation.
    Wilson DM; Dotson RJ; Neely EK; Cohen P; Hintz RL; Rosenfeld RG
    Am J Dis Child; 1993 Jan; 147(1):63-5. PubMed ID: 8380310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral clonidine for screening of growth hormone deficiency.
    Romer TE; Rymkiewicz-Kluczynska B; Bogoniowska Z
    Panminerva Med; 1982; 24(3):231-5. PubMed ID: 7177689
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral clonidine-an effective growth hormone-releasing agent in prepubertal subjects.
    Lanes R; Hurtado E
    J Pediatr; 1982 May; 100(5):710-4. PubMed ID: 7040621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The growth hormone response to clonidine in acute and remitted depressed male patients.
    Siever LJ; Trestman RL; Coccaro EF; Bernstein D; Gabriel SM; Owen K; Moran M; Lawrence T; Rosenthal J; Horvath TB
    Neuropsychopharmacology; 1992 May; 6(3):165-77. PubMed ID: 1599607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance of the oral clonidine test in 75 pediatric patients.
    De Angelis R; Pellini C; Petecca C; Uboldi F; di Natale B
    J Endocrinol Invest; 1988 May; 11(5):379-82. PubMed ID: 3053867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Statistic study of 5,473 somatotropin secretion stimulation pharmacologic tests (n=9). Proposed weighting coefficient].
    Rochiccioli P; Enjaume C; Tauber MT; Pienkowski C; Oliver I
    Ann Pediatr (Paris); 1993 Sep; 40(7):391-5. PubMed ID: 8239389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose oral clonidine. A simple and reliable growth hormone screening test for children.
    Lanes R; Recker B; Fort P; Lifshitz F
    Am J Dis Child; 1985 Jan; 139(1):87-8. PubMed ID: 3969992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and pharmacodynamics of orally administered clonidine: a model-based approach.
    Klein RH; Alvarez-Jimenez R; Sukhai RN; Oostdijk W; Bakker B; Reeser HM; Ballieux BE; Hu P; Klaassen ES; Freijer J; Burggraaf J; Cohen AF; Wit JM
    Horm Res Paediatr; 2013; 79(5):300-9. PubMed ID: 23735833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficient diagnosis of hypothalamo-hypophyseal nanism: 5 years' experience with the clonidine stimulation test in the diagnosis of growth hormone secretion].
    Lebl J; Dvorák P; Zizkovský V
    Cesk Pediatr; 1990 Nov; 45(11):648-50. PubMed ID: 2092912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.